Endexx Corp
OTC:EDXC
Endexx Corp
Research & Development
Endexx Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Endexx Corp
OTC:EDXC
|
Research & Development
-$27.1k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Research & Development
-$14.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Research & Development
-$9.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Research & Development
-$10.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Research & Development
-$15.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Research & Development
-$13.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
Endexx Corp
Glance View
Endexx Corp. is a diversified holding company, which engages in the plant-based nutraceuticals and emerging technologies. The company is headquartered in Cave Creek, Arizona. The company went IPO on 2001-08-03. Through its subsidiaries, the Company sells CBD oils, capsules, topicals, and pet products, all with the shared purpose of supporting the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce Website, as well as other online and in-store retailers. In addition to its consumer products, its Gorilla-Tek division offers an automated dispensing system providing a method of distributing hemp-based products. The firm also owns and operates a number of wholly-owned subsidiaries that offer technology and consulting solutions to the hemp and CBD industry, including a Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform. The company formulates and develops products to improve quality of life.
See Also
What is Endexx Corp's Research & Development?
Research & Development
-27.1k
USD
Based on the financial report for Sep 30, 2022, Endexx Corp's Research & Development amounts to -27.1k USD.
What is Endexx Corp's Research & Development growth rate?
Research & Development CAGR 3Y
-13%
Over the last year, the Research & Development growth was -166%. The average annual Research & Development growth rates for Endexx Corp have been -13% over the past three years .
